e-Edition
Obituaries
In Loving Memory
Magazines
Subscribe
Login to Comment
Register
jobs
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Life
Commentary
Contact
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
27.39
-0.18 (-0.67%)
Streaming Delayed Price
Updated: 3:10 PM EST, Feb 17, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
22,944,915
Open
27.84
Bid (Size)
27.39 (6,400)
Ask (Size)
27.40 (7,200)
Prev. Close
27.58
Today's Range
27.20 - 27.87
52wk Range
20.91 - 27.94
Shares Outstanding
5,606,688,356
Dividend Yield
6.28%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
1 Reason I'd Buy Eli Lilly Stock and Never Sell
↗
Today 12:35 EST
A robust pipeline is essential for a buy-and-hold pharmaceutical stock.
Via
The Motley Fool
Topics
Intellectual Property
Pfizer's Cancer Drug Combo Shows Strong Results In Key Colorecatal Cancer Trial
↗
Today 10:15 EST
Pfizer's Braftovi combo improves survival in advanced colorectal cancer trial.
Via
Benzinga
Performance
YTD
+8.8%
+8.8%
1 Month
+7.3%
+7.3%
3 Month
+9.2%
+9.2%
6 Month
+9.3%
+9.3%
1 Year
+7.2%
+7.2%
More News
Read More
Moderna’s mRNA Renaissance: Navigating Volatility and the Post-Pandemic Pipeline
Today 10:06 EST
Via
Finterra
Topics
Economy
Intellectual Property
Pfizer’s BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer
Today 6:45 EST
From
Pfizer Inc.
Via
Business Wire
2 S&P 500 Stocks to Research Further and 1 We Question
February 16, 2026
Via
StockStory
Topics
Stocks
2 Value Stocks Worth Your Attention and 1 We Brush Off
February 16, 2026
Via
StockStory
The Great Inflation Thaw: US Price Pressures Hit Five-Year Low as Federal Reserve Eyes 2026 Pivot
February 16, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Economy
ASCO GU 2026: Merck and Protara Poised to Disrupt Bladder and Kidney Cancer Standards
February 16, 2026
Via
MarketMinute
Topics
Intellectual Property
3 S&P 500 Stocks Worth Investigating
February 15, 2026
Via
StockStory
Topics
Stocks
What Is One of the Best Pharmaceutical Stocks to Own for the Next 10 Years?
↗
February 14, 2026
Via
The Motley Fool
Topics
Intellectual Property
Moderna Shares Surge as Aggressive Cost-Cutting and Post-Pandemic Pivot Take Hold in Q4 Results
February 13, 2026
Via
MarketMinute
Topics
Earnings
Hospitals Stand Tall: Healthcare Sector Becomes Safe Haven Amid "Warsh Shock" and Tech Volatility
February 13, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Earnings
Economy
The Great 2026 Divergence: Tech Titans Rise on AI Execution While Healthcare Reaps a Regulatory Whirlwind
February 13, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
Meet the 6.3% Yield Dividend Stock That Could Soar in 2026
↗
February 13, 2026
Via
The Motley Fool
Topics
Intellectual Property
Healthcare’s Renaissance: Sector Outshines Tech as Policy Clarity Sparks Q4 Surge
February 12, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
World Trade
S&P 500 Breaches 7,000 Milestone: AI Megacaps Propel Market to Historic Heights
February 12, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Stocks
Alnylam Pharmaceuticals (ALNY): The RNAi Pioneer’s 2026 Breakout and the Battle for Cardiovascular Dominance
February 12, 2026
Via
Finterra
Topics
Economy
Intellectual Property
Zoetis Inc. (ZTS): Navigating Innovation and Safety in a Mature Animal Health Market
February 12, 2026
Via
Finterra
Topics
Artificial Intelligence
Earnings
Economy
FDA Stuns Moderna with Refusal to Review Flu Vaccine, Sending Shares Tumbling 3.5%
February 12, 2026
Via
MarketMinute
Topics
Earnings
Zoetis’s (NYSE:ZTS) Q4 CY2025 Sales Top Estimates
February 12, 2026
Via
StockStory
Pfizer Reports Strong Earnings Outlook - Unusual Call Options Activity Shows Investors Are Bullish
↗
February 11, 2026
Via
Talk Markets
Is Now the Best Time to Buy Pfizer Stock?
↗
February 11, 2026
Via
The Motley Fool
Topics
Intellectual Property
Pfizer Reports Strong Earnings Outlook - Unusual Call Options Activity Shows Investors are Bullish
February 11, 2026
Via
Barchart.com
Healthcare Stocks Are Sinking. Here Are 2 to Buy on the Dip.
↗
February 11, 2026
Via
The Motley Fool
Moderna (MRNA) Deep Dive: Navigating Regulatory Blows and the Pivot to Oncology
February 11, 2026
Via
Finterra
Topics
Artificial Intelligence
Initial Public Offering
Intellectual Property
Frequently Asked Questions
Is Pfizer publicly traded?
Yes, Pfizer is publicly traded.
What exchange does Pfizer trade on?
Pfizer trades on the New York Stock Exchange
What is the ticker symbol for Pfizer?
The ticker symbol for Pfizer is PFE on the New York Stock Exchange
What is the current price of Pfizer?
The current price of Pfizer is 27.39
When was Pfizer last traded?
The last trade of Pfizer was at 02/17/26 03:10 PM ET
What is the market capitalization of Pfizer?
The market capitalization of Pfizer is 153.60B
How many shares of Pfizer are outstanding?
Pfizer has 154B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
wpDiscuz
Insert